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Abstract 
Previous research has demonstrated links between Anorexia Nervosa (AN) and Autism 
Spectrum Disorder (ASD), however, few studies have examined the possible impact of 
symptoms of ASD on clinical outcomes in AN. The aim of this study was to examine the 
association between symptoms of ASD, eating disorder and other psychopathology 
during the course of inpatient treatment in individuals with AN. Participants with AN 
(n=171) completed questionnaires exploring eating disorder psychopathology, 
symptoms of depression and anxiety and everyday functioning at both admission and 
discharge. Characteristics associated with ASD were assessed using the AQ-10. ASD 
symptoms were significantly positively correlated with eating disorder 
psychopathology, work and social functioning and symptoms of depression and anxiety, 
but not with BMI. AQ-10 scores remained relatively stable from admission to discharge 
but there was a small, significant reduction in scores. There was no interaction between 
time and AQ-10 scores on clinical symptom change. In AN, ASD symptoms appear to be 
associated with a more severe clinical presentation on admission to inpatient care. ASD 
symptoms as assessed by self-report measures may be exacerbated by other mental 
health psychopathology, which warrants further investigation.  
Keywords 
Anorexia Nervosa; Autism Spectrum Disorder; ASD; AQ-10; eating disorder 
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Background 
Anorexia Nervosa (AN) is an eating disorder characterized by deliberate weight loss; an 
intense fear of gaining weight and distorted body image (APA, 2013).The disorder is 
associated with high morbidity (Treasure et al., 2010) and mortality rates (Fichter and 
Quadflieg, 2016), as well as functional and social impairment (Tchanturia et al., 2013a; 
Harrison et al., 2014). Despite the high risks associated with the disorder, the evidence 
for successful treatment for AN in adults is limited (NICE, 2004). Challenges in treating 
severe AN include malnutrition, poor attention and inefficiencies in cognitive 
processing, which may limit patients’ ability to benefit fully from psychological 
treatments (Tchanturia et al., 2011; Tchanturia et al., 2012b; Lang et al., 2014). Thus, 
over the last few years, treatment focus has started to shift from core eating disorder 
symptoms to other factors thought to maintain the disorder (Treasure and Schmidt, 
2013).  
Up to 97% of patients hospitalized for the treatment of AN experience at least one 
psychiatric co-morbidity (Blinder et al., 2006) making it an important factor to consider 
in treatment. Major Depressive Disorder is the most common comorbidity in AN (Kaye, 
2008), and has been linked to a worse treatment outcome (Lowe et al., 2001). 
Generalized Anxiety Disorder (Godart et al., 2002; Kaye et al., 2004; Cederlof et al., 
2015), has also been found to impede clinical outcomes of treatment. Possible co-
morbidity between  AN and Autism Spectrum Disorder (ASD) has received recent 
research attention, arising from observed similarities between the two disorders, with 
patients with AN showing inflexibility and poor social functioning, possibly reflecting 
the presence of an underlying ASD (Gillberg, 1983).  
Both cognitive (Oldershaw et al., 2011; Tchanturia et al., 2012b; Westwood et al., 2016b) 
and socioemotional (Tchanturia et al., 2004; Nowakowski et al., 2013; Davies et al., 
2016; Tchanturia et al., 2012a; Doris et al., 2014; Westwood et al., 2016a) similarities 
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between ASD and AN have been observed. Several studies have also explored the 
presence of elevated ASD symptoms in adults with AN (Huke et al., 2013; Westwood et 
al., 2015; Westwood et al., 2017b; Mandy and Tchanturia, 2015; Vagni et al., 2016; Bentz 
et al., 2017),  suggesting that adults with AN exhibit higher levels of symptoms 
characteristic of ASD than the general population, with an estimated prevalence rate of 
around 23% (Huke et al., 2013; Westwood et al., 2017b). It is important to note that the 
presence of ASD symptoms in AN appears to differ across age groups and stages of the 
illness, suggesting that similarity between the two disorders may at least in part arise 
because of starvation or chronicity of AN. Thus, individuals with AN may only 
superficially resemble those with ASD (Mandy and Tchanturia, 2015; Westwood et al., 
2017a; Bentz et al., 2017), rather than having a neurodevelopmental disorder. 
Examining the stability of ASD symptoms over the course of treatment for AN will speak 
to debates over whether behaviours characteristic of ASD are  exaggerated, arising from 
the ill-state associated with AN (Hiller and Pellicano, 2013).  
Research examining the effect of ASD symptoms on treatment outcome in AN has found 
a poorer prognosis when ASD symptoms are elevated (Nielsen et al., 2015; Stewart et al., 
2017). Therefore, patients with AN and elevated symptoms of ASD may respond 
particularly poorly to standard treatment for AN (Goddard et al., 2013; Tchanturia et al., 
2013b; Tchanturia et al., 2016). However, a small-scale pilot research suggested lower 
treatment drop-out in individuals with elevated ASD symptoms (Huke et al., 2014). 
Thus, more work is needed to clarify the clinical needs and necessary treatment 
adaptions for elevated ASD symptoms in AN. Better understanding of these symptoms 
could help improve service delivery and enable clinical teams to develop and enhance 
skills to provide tailored interventions.  
The aim of this naturalistic study is to examine the association between symptoms of 
ASD and eating disorder and other psychopathology in patients with AN and to examine 
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whether changes in psychopathology during the course of inpatient treatment are 
dependent on ASD symptoms.  
The specific research questions were as follows: 
1. Is the level of self-reported symptoms of ASD associated with more severe eating 
disorder and other psychopathology at admission?    
2. Are ASD symptoms stable over the course of inpatient admission? 
3. Are changes in self-reported psychopathology and eating disorder symptoms 
associated with the severity of ASD symptoms?  
Method 
Participants  
All participants, n=171, were part of an inpatient treatment programme at South 
London and Maudsley NHS Foundation Trust and had a DSM-5 diagnosis of AN (APA, 
2013) on admission. Participants had a mean age of 27.3 years, mean age of AN onset of 
16.18 years, a mean BMI of 14.1 on admission and an average length of treatment of 16 
weeks. For a more detailed analysis of the participant’s demographic information, see 
Table 1. As the sample was recruited from a clinical programme, there were no specific 
inclusion/exclusion criteria. All patients received a self-report questionnaire pack at 
admission and discharge. 
Measures 
Body Mass Index (BMI; kg/m2) was taken from clinical notes on the day of the 
completion of the questionnaires on admission and discharge. Demographic variables 
were collected from participants and in case of missing data they were obtained from 
the clinical notes. Participants completed self-report questionnaires within a week of 
admission and no earlier than a week before discharge. The Hospital Anxiety and 
Depression Scale (HADS) was introduced to the audit questionnaire pack three years 
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later than the other measures and is hence reflected in the results as a lower response 
rate.  
Autism-Spectrum Quotient, short version (AQ-10; Allison et al., 2012):  
Participants completed the AQ-10 as part of their questionnaire packs on admission and 
discharge. The AQ-10 is a brief, ten-item, self-report questionnaire originally designed 
for use as a screening questionnaire for ASD. It shows equivalent validity to the longer 
version of the AQ (Booth et al., 2013), with a clinical cut-off of six indicating possible 
ASD. It has been used widely within eating disorder research to differentiate individuals 
with AN from healthy controls on level of ASD symptoms (Westwood et al., 2015). As the 
measure was designed as a screening tool and not a diagnostic measure, we treated the 
scores as a continuous variable with higher scores indicating an increase in autistic 
symptoms. This is also in line with the notion of ASD being a dimensional disorder 
(Wiggins et al., 2012), with sub-clinical symptoms extending into the general 
population.  
Eating Disorder Examination Questionnaire (EDE-Q; Fairburn and Beglin, 1994): 
A 36-item self-report measure looking at ED symptomatology and behaviours over the 
last 28 days. The questionnaire provides scores across four subscales (Dietary Restraint, 
Weight Concern, Shape Concern and Eating Concern) as well as a Global score, which 
reflects overall illness severity. In the current study, the overall Cronbach alpha 
coefficient was .98. 
Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983): 
A 14-item self-report questionnaire assessing presence and severity of depression and 
anxiety traits during the past week. The clinical cut off score is >10 for both depression 
and anxiety subscales, with a maximum possible score of 21. In the current study, the 
overall Cronbach alpha coefficient was .86.  
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Work and Social Adjustment Scale (WSAS; Mundt et al., 2002): 
A 5-item self-report measure assessing the extent of impairment in the following 
domains: home management, ability to work, both social and private leisure, and ability 
to form and maintain close relationships. Each domain is scored on an 9-point Likert 
scale, ranging from 0 (no impairment) to 8 (very severe impairment). The maximum 
total score is 40, with a clinical cut off is 20 and above. In the current study, the overall 
Cronbach alpha coefficient was .85. 
Data analysis:  
All statistical analyses were conducted with Stata 14 (Stata Corp.). Significance 
threshold was set at p < 0.05. Additionally, effect size of change in psychopathology from 
admission to discharge was estimated by calculating standardized mean change with 
change score standardization. The effect size estimates were interpreted as small (≥ 
|0.2|), medium (≥ |0.5|), and large (≥ |0.8|) (Hedges, 1981).  
Association between AQ-10 and eating disorder/other psychopathologies 
The association between AQ-10 scores and eating disorder/other psychopathology was 
assessed using Kendall’s tau-b (τb) correlation coefficient at admission to assess if those 
who score high on the AQ-10 come into hospital with other more severe 
psychopathology. The correlation analyses were corrected for multiple comparisons by 
adjusting the confidence intervals with the Bonferroni method. 
Stability of AQ-10 scores over admission 
AQ-10 scores were checked for stability over time by looking at the linear relationship 
between patients’ admission and discharge scores using Kendall’s tau-b. Secondly, 
Wilcoxon signed rank test was conducted to investigate significant changes in the AQ-10 
score from admission to discharge. 
  
8 
Relationship between AQ-10 score and clinical symptom change  
To investigate the association between AQ-10 scores and clinical symptom change over 
the course of admission, only participants who had completed questionnaires at 
admission are included. Drop-out rates were defined as non-completion of discharge 
questionnaires with common reasons being: not returning questionnaires, refusal to 
complete questionnaires, discharged prematurely and self-discharge from service. To 
allow the data to be analysed despite of drop-out, we conducted mixed effects analysis 
with time (admission, discharge) and AQ-10 scores as fixed effects predictors along with 
a random intercept. Any autocorrelation in the residuals was adjusted with the AR(1) 
autoregressor. All data met the assumptions for mixed effects analysis.  
Results 
Patient Characteristics 
Self-reported psychopathology at admission and discharge is presented in Table 1. 
Based on the 95% confidence intervals, there were significant improvement in all 
measures of psychopathology and BMI with small to large effect sizes. All participants 
were female and were aged between 18 and 55 years with a mean age of onset of AN 
was 16.2 years (SD=6), leading to a mean illness duration of 10.8 years (SD=8.5). 58% 
percent of participants had restrictive AN, 33% had a diagnosis of AN binge-purge, and 
9% had a diagnosis of atypical AN.  
Table 1. Self-reported psychopathology and BMI at admission and discharge 
 Admission Discharge  95% CI 
Scale Mean SD Mean SD SMCC Lower 
bound 
Upper 
bound 
EDE-Q 3.85 1.66 2.80 1.65 -0.76 -0.99 -0.53 
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WSAS 26.54 8.85 20.95 10.71 -0.54 -0.76 -0.32 
HADS 
anxiety 
14.71 4.49 12.28 5.16 -0.40 -0.63 -0.16 
HADS 
depression 
11.73 4.98 7.53 5.05 -0.63 -0.88 -0.38 
AQ-10 3.86 2.45 3.42 2.34 -0.27 -0.49 -0.06 
BMI 14.15 1.66 16.31 1.90 1.51 1.29 1.74 
EDE-Q = Eating disorder examination questionnaire; WSAS = Work and social adjustment 
scale; HADS = Hospital anxiety and depression scale; AQ-10 = Short autism-spectrum 
quotient; BMI = Body mass index; SMCC = standardized mean change with change score 
standardization; CI = confidence interval. 
Association between AQ-10 and eating disorder/other psychopathology 
Results of Kendall's tau-b correlation analysis, to determine the relationship between 
AQ-10 total score and other psychopathology scores at admission are displayed in Table 
2. There was a significant positive correlation between AQ-10 and EDE-Q, WSAS, HADS 
Anxiety and HADS Depression, indicating that those reporting higher incidence of ASD 
symptoms also tend to report higher incidence of other psychopathology.  
Table 2. Correlation between AQ-10 scores and psychopathology and BMI at admission 
Scale Correlation coefficient (τb) p-value 
EDE-Q 0.29 0.0001 
WSAS 0.22 0.009 
HADS: Anxiety 0.27 0.001 
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HADS: Depression 0.23 0.008 
BMI 0.15 0.361 
The confidence intervals were adjusted for multiple comparisons using the 
Bonferroni method. Significance was set at p < 0.05. 
Stability of AQ-10 scores over time 
The results of the Kendall’s tau correlation show that there was a medium sized 
correlation between admission and discharge AQ-10 scores (τb = 0.56, p < .001), 
suggesting the scores are reasonably stable over time. There was, however, small 
decrease in AQ-10 scores between admission and discharge (SMCC = -0.27, 95% CI [ -
0.49, -0.06]), which was statistically significant (Z = 2.33, p = 0.020). 
Relationship between AQ-10 scores and clinical symptom change of the course of 
admission  
Depression 
The mixed effects analysis showed that, as expected, there was a significant negative 
relationship between time and self-reported depression (Z = -2.88, p = 0.004, 95% CI [-
5.00, -0.95]).  There was also a significant positive relationship between AQ-10 scores 
and self-reported depression (Z = 4.01, p < 0.001, 95% CI [0.35, 1.01]). There was no 
significant time x AQ-10 interaction (Z = -0.27, p = 0.788, 95% CI [-0.57, 0.43]). These 
results indicate that the relationship between AQ-10 and self-reported depression was 
reasonably constant from admission to discharge with those reporting high incidence of 
ASD symptoms also reporting more depressive symptoms. 
Anxiety  
The mixed effects model revealed a significant positive relationship between AQ-10 
scores and self-reported anxiety (Z = 4.12, p < 0.001, 95% CI [0.35, 0.98]). Surprisingly, 
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there was no significant negative relationship between time and self-reported anxiety (Z 
= -1.83, p = 0.067, 95% CI [-3.43, 0.12]). There was also no significant time x AQ-10 
interaction (Z = -0.06, p = 0.953, 95% CI [-0.46, 0.43]). These results indicate that the 
relationship between AQ-10 scores and self-reported anxiety was reasonably constant 
from admission to discharge with those reporting high incidence of ASD symptoms also 
reporting more anxiety. 
Eating Disorder Symptoms  
As expected, the mixed effects analysis revealed a significant negative relationship 
between time and self-reported ED symptoms (Z = -3.05, p = 0.002, 95% CI [-1.25, -
0.27]). There was also a positive relationship between AQ-10 scores and self-reported 
ED psychopathology such that those reporting more ED symptoms also reported more 
ASD symptoms (Z = 3.67, p < 0.001, 95% CI [0.08, 0.27]). There was no significant r time 
x AQ-10 interaction (Z = -0.72, p = 0.0.471, 95% CI [-0.16, 0.07]). These results suggest 
that the relationship between self-reported ASD and ED symptoms was reasonably 
constant from admission to discharge.  
Body mass index (BMI) 
The mixed effects model showed that there was a significant positive relationship 
between time and BMI (Z = 9.04, p < 0.001, 95% CI [2.00, 3.10]), as expected. Unlike 
with the above self-reported ED psychopathology, there was no significant relationship 
between AQ-10 scores and BMI (Z = 1.57, p = 0.116, 95% CI [-0.02, 0.18]). There was 
also no significant time x AQ-10 interaction (Z = -0.39, p = 0.697, 95% CI [-0.16, 0.10]). 
Work and social adjustment 
As anticipated, the mixed effects analysis showed a significant negative relationship 
between time and WSAS score (Z = -2.95, p = 0.003, 95% CI [-9.04, -1.82]). There was 
also a significant positive relationship between AQ-10 and WSAS scores (Z = 4.26, p < 
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0.001, 95% CI [0.68, 1.84]). There was no significant time x AQ-10 interaction (Z = 0.45, 
p = 0.655, 95% CI [-0.66, 1.04]). These results indicate that the relationship between AQ-
10 and WSAS was reasonably constant across time with those reporting more ASD 
symptoms also report more difficulties in work and social adjustment. 
Discussion 
The aim of this naturalistic study was to explore the association between ASD symptoms 
and both eating disorder and other psychopathology and functioning in patients 
hospitalized for AN. The results indicate that symptoms of ASD, as measured by the AQ-
10 are significantly, positively associated with both eating disorder and other 
psychopathology, as measured by the EDE-Q, WSAS, HADS Anxiety and HADS 
Depression. This suggests that individuals who report higher levels of symptoms 
associated with ASD also tend to report higher incidence of other psychopathology.  
These results are in line with the few previous studies which have examined ASD 
symptoms in women with AN. For example, Westwood et al. (2017b) found that 
symptoms of ASD were associated with increased alexithymia and obsessive-compulsive 
symptoms. However, they did not find any association between symptoms of anxiety or 
depression or specific eating disorder pathology, including BMI. However, as Westwood 
and colleagues (2017b) used a direct-observational assessment of ASD, namely the 
Autism Diagnostic Observation Schedule, 2nd edition (ADOS-2; Lord et al., 2012), the 
results are not directly comparable. Interestingly, while in this study EDE-Q scores were 
significantly positively correlated with AQ-10 scores, BMI was not. This was also the 
case in both Westwood and colleagues studies with adults (2017b) and adolescents with 
AN (Westwood et al., 2017a). This could suggest that while ASD symptoms are 
associated with eating disorder psychopathology in AN, they are not associated with the 
physical symptoms accompanying the disorder, such as low body weight, malnutrition 
or starvation. This is contrary to previous suggestion that such physical symptoms could 
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exacerbate the relationship between AN and ASD (Hiller and Pellicano, 2013). While it is 
not possible to separate the physical and psychological consequences of AN, this is an 
area which would benefit from future research.   
The second finding of this study was that while AQ-10 scores are relatively stable over 
the course of admission, there was a small yet significant reduction in these scores 
between admission and discharge. Given that ASD is a pervasive developmental 
disorder, developing during the early developmental period, with symptoms persisting 
into adulthood (NICE, 2012), one would not expect to see a reduction in such symptoms 
during an inpatient admission. This suggests that the AQ-10 may not just be measuring 
characteristics of ASD but may also be assessing symptoms associated with more 
general psychopathology, including symptoms of anxiety, depression or difficulties with 
general functioning.  
This argument is supported by the finding here that all measures of psychopathology 
(EDE-Q, HADS, WSAS) were significantly positively correlated with the AQ-10. The AQ-
10 focuses on current symptoms rather than assessing characteristics of ASD present 
earlier in life and despite being validated as a screening tool for use with adults (Booth 
et al., 2013), previous research has suggested that the AQ may not be .sensitive in 
detecting ASD in individuals with psychiatric disorders (Lugnegard et al., 2015). There 
is also evidence that scores on the AQ are less stable in females than in males 
(Whitehouse et al., 2011), although this study looked at individual scores over several 
years rather than a few months. Nevertheless, it might be that in individuals with severe 
AN, the AQ-10 is not sensitive enough to differentiate characteristics of ASD from other 
psychopathology, highlighting need for the development of brief, reliable tools for 
assessing ASD in psychiatric populations (Westwood and Tchanuria, 2017).  
The mixed effect analysis showed that patient’s self-report depression and eating 
disorder symptoms improved during the course of inpatient treatment. There was also a 
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signficiant increase in BMI and improvement in work and social functioning. While this 
was expected given the objectives of inpatient treatment, improvements in 
psychological symptoms, BMI and functioning were not influenced by or dependent on 
AQ-10 scores. However, individuals who reported higher levels of symptoms of ASD also 
reported higher levels of other clinical symptoms, irrespective of time. This suggests 
that while symptoms associated with ASD may not effect outcome, individuals with 
these symptoms may have more severe psychopathology in general compared with 
individuals without symptoms of ASD.  
These findings support previous research suggesting pooer outcome in individuals with 
both AN and elevated symptoms of ASD (Stewart et al., 2017; Nielsen et al., 2015). In the 
study presented here, symptoms of ASD did not influence the outcome of inpatient 
treatment but individuals with such symptoms had more severe eatign disorder and 
depressive symptoms and poorer work and social functioning. This suggests that 
indivduals with charactersitics of ASD may require longer or more intensive treatment 
for AN, although it is not yet known whether such individuals would benefit from 
specifically tailored care pathways.  
Interestingly, despite the effect size estimate showing a small, signficiant reduction in 
HADS anxirty scores from admission to discharge, when AQ-10 scores are included in 
the model as a predictor, there is no longer a signficiant reducion in HADs anxiety scores 
over time. There was no signficiant interaciton between time and AQ-10 scores for 
anxiety but there may be a relationship between HADS anxiety and the AQ-10 which 
was not detected  within mediation analysis here. This oculd be due to statistical issues, 
i.e., using count (AQ-10) versus continuous (HADS anxiety) outcomes. However, the 
possible relationship between self-report depression and ASD symptom scores warrents 
further investigaiton.  
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Limitations 
This study was based on naturalistic observations and therefore, the etiology or nature 
of the relationship between ASD symptoms and psychopathology cannot be inferred. 
While it is possible that the presence of ASD symptoms exacerbate symptoms of 
depression, anxiety and eating disorder pathology, the reverse may also be true, 
particularly as the AQ-10 measures current symptoms rather than assessing 
developmental history of ASD. Studies utilizing a longitudinal design, which assess ASD 
prior to the onset of AN will help delineate the relationship between these disorders.  
The study was conducted in one, inpatient eating disorder service so is not widely 
generalizable. There is a possibility that individuals hospitalized for AN, at the more 
severe end of the eating disorder spectrum, are more likely to have elevated symptoms 
of ASD. The presence of ASD symptoms has been associated with greater need for 
treatment augmentation in adolescents (Stewart et al., 2017) and therefore such 
symptoms may be over-represented in adult inpatient samples.  
Clinical implications 
Both AN and ASD are difficult conditions to manage clinically, particularly given the high 
levels of co-morbidities apparent in both disorders (Russell et al., 2016; Blinder et al., 
2006) and further research and developments are needed to tailor strategies to help 
individuals with both conditions (Anckarsater et al., 2012; Baron-Cohen et al., 2013; 
Tchanturia et al., 2016). In both ASD and AN, a gap in the literature has been 
acknowledged in terms of adult service provision (Howlin and Moss, 2012; Goddard et 
al., 2013) In AN, recent treatment developments have included adaptations to specific 
maintenance factors of the disorder. Cognitive Remediation Therapy (CRT) has been 
developed to address cognitive characteristics including cognitive inflexibility and 
detail-focused thinking (For a review, see Tchanturia et al., 2014). Cognitive 
Remediation and Emotion Skills Training (CREST) addresses poor recognition and 
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expression of emotions (Tchanturia et al., 2015) and the Maudsley Model of Anorexia 
Treatment for Adults (MANTRA; Schmidt et al., 2012) shows promise for patients 
with severe AN. Importantly, these treatments target the shared features between AN 
and ASD but further studies to assess their efficacy for individuals with both AN and 
elevated symptoms of ASD are needed.  
Conclusion 
The findings presented here suggest that in adults hospitalized for AN, the presence of 
symptoms characteristic of ASD is associated with more severe eating disorder, 
depression and anxiety symptoms and poorer everyday functioning. While the presence 
of ASD symptoms did not influence the outcome of admission directly, individuals with 
both AN and elevated symptoms of ASD may require longer or more intensive treatment 
packages.  
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